Search

everythinglearnresearchcommunity

for

Search:↓

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

The study improved and was accepted despite initial concerns about data clarity, methodology, and potential overfitting.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

The document concludes that the new expert system can assess the risk of PCOS effectively despite uncertainties in diagnosis.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Reviewers suggested the study on finding new drug uses through social media side-effects needs better methods and clearer limitations.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

MicroRNAs could help assess and manage multiple chronic diseases.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Social media can help compare the effectiveness and safety of new arthritis medications.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Reviewers criticized the study's methods and suggested focusing on drug mechanisms instead of repositioning due to social media data quality concerns.

Many medications may be linked to cognitive disorders, but most lack warnings on labels.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Using electronic health records can help identify drug side effects but has some limitations.

Nonpharmaceutical Traditional Chinese Medicine therapies for rheumatoid arthritis have been increasingly researched over the past 20 years.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Glucocorticoid corticosteroids improve muscle strength in Duchenne muscular dystrophy but can cause side effects.

Spironolactone may reduce excessive hair growth in women but its effectiveness for acne is not supported.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

Enteral nutrition's role in maintaining Crohn's disease remission is unclear and needs more research.